
Single-Port Laparoscopic Surgery Devices Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.

Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The global single-port laparoscopic surgery devices market size was valued at USD 834 million in 2024. The market is expected to grow from USD 904.2 million in 2025 to USD 1.9 billion in 2034, at a CAGR of 8.6% during the forecast period, according to the latest report published by Global Market Insights Inc. The high market growth is attributed to increasing prevalence of obesity, colorectal diseases, and gynecological conditions, along with the rising preference for minimally invasive surgery and a surge in outpatient surgeries, among other factors.

Single-port laparoscopic surgery (SPLS) devices represent a transformative advancement in minimally invasive surgery, enabling surgeons to perform complex procedures through a single incision, typically at the umbilicus, thereby minimizing trauma, scarring, and recovery time. Leading manufacturers such as Applied Medical, Medtronic, Johnson & Johnson, Olympus, and B. Braun offer comprehensive SPLS portfolios that include multi-channel access ports, articulating laparoscopic instruments, and advanced single-port platforms. These solutions are designed to optimize surgical ergonomics, enhance instrument triangulation, and improve procedural efficiency.
The market has increased from USD 715 million in 2021 and reached USD 782.9 million in 2023, with a historic growth rate of 4.6%. This expansion has been driven by the rising demand for minimally invasive surgical techniques, increasing adoption of single-incision procedures across general and gynecological surgeries, and the integration of advanced technologies such as articulating instruments and enhanced access devices.
Patients and healthcare providers are increasingly favoring procedures that offer reduced trauma, shorter hospital stays, faster recovery times, and improved cosmetic outcomes. Unlike traditional open surgeries, minimally invasive approaches such as single-port laparoscopy require only small incisions, significantly lowering the risk of infection and postoperative complications. This shift is further supported by advancements in surgical instrumentation, imaging technologies, and perioperative care, which have collectively enhanced the safety, precision, and efficacy of these procedures.
Additionally, growing awareness among patients regarding the benefits of reduced postoperative pain, faster recovery, and improved cosmetic outcomes has further accelerated market uptake. The expansion of ambulatory surgical centers and favorable reimbursement policies in developed markets have also contributed to sustained growth.
Single-port laparoscopic surgery devices are specialized medical instruments designed to facilitate minimally invasive surgical procedures through a single incision, typically made at the umbilicus.
| Key Takeaway | Details |
|---|---|
| Market Size & Growth | |
| Base Year | 2024 |
| Market Size in 2024 | USD 834 Million |
| Market Size in 2025 | USD 904.2 Million |
| Forecast Period 2025 - 2034 CAGR | 8.6% |
| Market Size in 2034 | USD 1.9 Billion |
| Key Market Trends | |
| Drivers | Impact |
| Increasing prevalence of obesity, colorectal diseases, and gynecological conditions | Expands the patient pool requiring surgical intervention, boosting demand for SPLS procedures. |
| Technological Advancements | Enhances surgical precision, safety, and outcomes, making SPLS more accessible and effective. |
| Rising preference for minimally invasive surgery | Drives adoption due to benefits like reduced pain, faster recovery, and better cosmetic results. |
| Surge in outpatient surgeries | Fuels demand for SPLS devices as they support quicker procedures with shorter hospital stays. |
| Pitfalls & Challenges | Impact |
| High cost of laparoscopic devices | Limits adoption in cost-sensitive markets and smaller healthcare facilities. |
| Stringent government regulations | Slows down product approvals and market entry for innovative SPLS technologies. |
| Opportunities: | Impact |
| Healthcare infrastructure expansion | Opens new markets and increases procedural volumes in emerging economies. |
| Development of flexible, ergonomic, and reusable instruments | Reduces costs and improves surgeon comfort, driving broader adoption. |
| Market Leaders (2024) | |
| Market Leaders |
~37.1% Market Share |
| Top Players |
Collective market share in 2024 is ~71% |
| Competitive Edge |
|
| Regional Insights | |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Emerging Country | China, India, Mexico, Brazil, and South Africa |
| Future Outlook |
|
Technological advancements are playing a critical role in accelerating the adoption and evolution of single-port laparoscopic surgery (SPLS) devices, transforming them into more precise, efficient, and user-friendly tools for minimally invasive procedures.

The global market was valued at USD 715 million in 2021. The market size reached USD 782.9 million in 2023, from USD 746.9 million in 2022.
Based on product type, the market is segmented into access devices and laparoscopic instruments. The access devices segment accounted for 57.8% of the market in 2024 due to their critical role in enabling single-incision entry, instrument navigation, and procedural efficiency across a wide range of laparoscopic surgeries. The segment is expected to exceed USD 1.1 billion by 2034, growing at a CAGR of 8.4% during the forecast period.
On the other hand, the laparoscopic instruments segment held a significant market share of 42.2% in 2024, and its growth can be attributed to the increasing demand for precision tools that enable complex maneuvers through a single incision, especially in anatomically constrained procedures. These instruments, such as articulating graspers, trocars, scissors, dissectors, and needle holders, are essential for maintaining surgical dexterity and control in single-port procedures, where instrument crowding and limited triangulation are common challenges.
Based on application, the single-port laparoscopic surgery devices market is segmented into general surgery, gynecological surgery, urological surgery, bariatric surgery, and other applications. The general surgery segment continues to dominate, accounting for a majority market share valued at USD 360.4 million in 2024.

Based on end use, the single-port laparoscopic surgery devices market is segmented into hospitals, ambulatory surgical centers, and other end users. The hospitals segment accounted for USD 564.2 million in 2024 and is expected to grow at an 8.6% CAGR from 2025 to 2034.

North America Single-Port Laparoscopic Surgery Devices Market
North America dominated the global market with the highest market share of 45% in 2024.
Europe Single-Port Laparoscopic Surgery Devices Market
Europe market accounted for USD 226.6 million in 2024 and is anticipated to show lucrative growth over the forecast period.
Asia Pacific Single-Port Laparoscopic Surgery Devices Market
The Asia Pacific market is anticipated to grow at a CAGR of 9.9% during the analysis timeframe.
Latin America Single-Port Laparoscopic Surgery Devices Market
The Latin America market is experiencing robust growth over the analysis timeframe.
Middle East & Africa Single-Port Laparoscopic Surgery Devices Market
The Middle East & Africa (MEA) market is experiencing notable growth over the analysis timeframe.
Leading industry players such as Applied Medical, Medtronic, Johnson & Johnson, Olympus, and B. Braun collectively hold a market share of approximately 71% in the competitive SPLS devices market. These companies maintain their dominance through continuous innovation in articulating instruments, multi-channel access platforms, and advanced single-port systems that enhance surgical precision, ergonomics, and patient outcomes. Their global distribution networks, surgeon education programs, and regulatory expertise enable widespread adoption across hospitals and ambulatory surgical centers, reinforcing their leadership in minimally invasive surgery.
Meanwhile, emerging players are carving out niches by focusing on cost-effective reusable instruments, flexible access ports, and region-specific device customization, particularly in Asia-Pacific and Latin America. Strategic collaborations with academic institutions, digital surgery platform providers are enabling these companies to introduce novel solutions that address unmet clinical needs. Overall, the SPLS devices market is evolving toward digitally integrated, patient-centric, and ergonomically optimized surgical systems, intensifying competition and driving continuous improvements in device performance, affordability, and procedural efficiency.
A few of the prominent players operating in the single-port laparoscopic surgery devices industry include:
Applied Medical is a recognized innovator in the SPLS space, known for its GelPOINT advanced access platforms that enable efficient single-incision procedures across general, colorectal, and gynecological surgeries. The company emphasizes ergonomic design, clinical versatility, and cost-effectiveness, making its devices highly suitable for both high-volume hospitals and ambulatory surgical centers. Applied Medical’s vertically integrated manufacturing model allows for rapid product development and customization, while its strong focus on surgeon education and procedural efficiency reinforces its reputation as a value-driven leader in minimally invasive surgery.
Ethicon, a subsidiary of Johnson & Johnson MedTech, holds a prominent position in the SPLS market with its SILS Port platform and a comprehensive suite of laparoscopic instruments and energy devices. The company’s strength lies in its ability to integrate SPLS solutions within a broader surgical ecosystem, offering standardized instrumentation, advanced visualization systems, and hemostatic technologies that enhance procedural outcomes.
Medtronic is a key player in the SPLS market, offering the widely adopted SILS Port system designed for single-incision laparoscopic access. The company’s SPLS portfolio is built around multi-channel access platforms and precision laparoscopic instruments that support a wide range of procedures, from general surgery to gynecology. Medtronic’s focus on instrument reliability, procedural standardization, and global accessibility has made its SPLS solutions a preferred choice in both developed and emerging markets.
Market, By Product Type
Market, By Application
Market, By End Use
The above information is provided for the following regions and countries:
Key players include Applied Medical, Medtronic, Johnson & Johnson (Ethicon), Olympus, B. Braun, CITEC, STORZ, LOOKMED, KANGJI, Hospiinz, GYTR-VII, and UNIMAX.
The Asia Pacific region is projected to grow at a CAGR of 9.9% through 2034, supported by rapid healthcare expansion, increasing surgical volumes, and growing awareness of the benefits of minimally invasive procedures.
North America led the global market with a 45% share (USD 375 million) in 2024, driven by advanced healthcare infrastructure, strong presence of key manufacturers, and favorable reimbursement frameworks for minimally invasive surgeries.
The hospitals segment dominated with USD 564.2 million revenue in 2024, owing to the high volume of complex surgical procedures, advanced operating room infrastructure, and surgeon access to training and robotic-assisted technologies.
The general surgery segment led the market with USD 360.4 million revenue in 2024, supported by the high procedural volume of cholecystectomy, appendectomy, and hernia repair, which are well-suited for single-port access.
The access devices segment held the largest share of 57.8% (USD 482.6 million) in 2024, driven by their essential role in enabling single-incision entry, instrument navigation, and maintaining pneumoperitoneum during surgical procedures.
The market size was USD 834 million in 2024, driven by the rising prevalence of obesity, colorectal, and gynecological disorders, along with the increasing adoption of minimally invasive surgical techniques.
The market is expected to reach USD 1.9 billion by 2034, growing at a CAGR of 8.6%, fueled by advancements in surgical technology, growing demand for outpatient procedures, and the integration of robotic and AI-assisted platforms.
The market is projected to reach USD 904.2 million in 2025, supported by increased preference for single-incision surgeries offering faster recovery, minimal scarring, and reduced postoperative complications.


